Maca Menopause Meta-analysis: What the Evidence Says
Maca Menopause Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic
Quick Answer
Maca Menopause Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 2 systematic review.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Maca Menopause Meta-analysis: What the Evidence Says
Quick Answer
Maca Menopause Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis | systematic review | 1 | 2026-01-05 | 10.3389/fnut.2025.1719711 |
| Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis | systematic review | 1 | 2025-12-08 | 10.3390/healthcare13243206 |
What The Sources Report
- The diameter of the hair shaft becomes thinner, pigmentation decreases, and the result is visibly progressive hair loss. [Zhou Lei (2026); evidence level 1]
- This definition and screening process aimed to reduce bias and ensure consistency in the evidence strength and comparability of the included interventions. [Zhou Lei (2026); evidence level 1]
- Common physical symptoms include decreased skin elasticity, reduced libido, headaches, cardiovascular issues, hot flashes, sleep disturbances, and facial flushing. [Kim Ji-Hyun (2025); evidence level 1]
- Psychological symptoms frequently include increased irritability and depressive symptomatology, such as feelings of worthlessness, fatigue, lack of motivation, and diminished concentration. [Kim Ji-Hyun (2025); evidence level 1]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For maca menopause meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Zhou Lei (2026). Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis. DOI: 10.3389/fnut.2025.1719711. PMCID: PMC12812558. PMID: 41561175. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12812558/
- Kim Ji-Hyun (2025). Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and Meta-Analysis. DOI: 10.3390/healthcare13243206. PMCID: PMC12732411. PMID: 41464280. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12732411/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed June 3, 2026 by Migaku Evidence Review
